David H. Ledbetter, PhD, FACMG

Executive Vice President/Chief Scientific Officer, Geisinger

Dr. Ledbetter is executive vice president and chief scientific officer at Geisinger.  Previously he held academic and leadership positions at Emory University, the University of Chicago, and the National Center for Human Genome Research at NIH. He is a graduate of Tulane University and earned his Ph.D. at the University of Texas-Austin.  He is an internationally recognized expert in Genomics and Precision Medicine, having focused his early research efforts on discovering the genetic causes of childhood neurodevelopmental disorders such as autism, and the translation of new genomics technologies into clinically useful genetic tests for early diagnosis and intervention. His current research interest includes leveraging longitudinal electronic health information with large-scale DNA sequencing to determine the clinical utility and cost-effectiveness of precision medicine approaches in a real-world health system setting.

Posted July 2020
Ledbetter

Geisinger’s Genomics and Precision Health Initiative, Part II

John Bulger, DO, MBA, Chief Medical Officer Population Health, Geisinger Health System and Chief Medical Officer of Geisinger Health Plan, ...
Read More

Precision Medicine at Geisinger – Making DNA Sequencing Part of Routine Clinical Care

John Bulger, DO, MBA, Chief Medical Officer Population Health, Geisinger Health System and the Chief Medical Officer of Geisinger Health ...
Read More